| C478160 | (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane | "[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in increased expression of MAP1LC3B protein modified form" | 28757135 |
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cadmium acetate affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein]]" | 28347754 |
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cadmium acetate affects the localization of [RAB7A protein co-treated with MAP1LC3B protein]]" | 28347754 |
| C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione results in decreased expression of MAP1LC3B mRNA" | 19162173 |
| C032668 | 1-nitropyrene | 1-nitropyrene results in increased expression of MAP1LC3B mRNA | 29078374 |
| C032668 | 1-nitropyrene | 1-nitropyrene results in increased expression of MAP1LC3B protein | 29078374 |
| C032668 | 1-nitropyrene | 1-nitropyrene results in increased expression of MAP1LC3B mRNA | 29078374 |
| C032668 | 1-nitropyrene | 1-nitropyrene results in increased expression of MAP1LC3B protein | 29078374 |
| C032668 | 1-nitropyrene | ATG7 protein affects the reaction [1-nitropyrene results in increased expression of MAP1LC3B protein] | 29078374 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "[PIK3CA gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in increased expression of MAP1LC3B mRNA" | 20453058 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] | 20479004 |
| C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MAP1LC3B mRNA" | 19114083 |
| C109986 | 2-aminoethoxydiphenyl borate | 2-aminoethoxydiphenyl borate inhibits the reaction [cadmium acetate affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein]] | 28347754 |
| C109986 | 2-aminoethoxydiphenyl borate | 2-aminoethoxydiphenyl borate inhibits the reaction [cadmium acetate affects the localization of [RAB7A protein co-treated with MAP1LC3B protein]] | 28347754 |
| C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased expression of MAP1LC3B mRNA] | 28184909 |
| C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased expression of MAP1LC3B protein] | 28184909 |
| C025946 | 3-methyladenine | 3-methyladenine affects the metabolism of MAP1LC3B protein | 23680031 |
| C025946 | 3-methyladenine | [3-methyladenine co-treated with TNF protein] results in decreased expression of MAP1LC3B protein alternative form | 24145604 |
| C025946 | 3-methyladenine | 3-methyladenine inhibits the reaction [E platinum results in increased expression of MAP1LC3B protein] | 22322152 |
| C025946 | 3-methyladenine | 3-methyladenine inhibits the reaction [E platinum results in increased metabolism of MAP1LC3B protein] | 22322152 |
| C025946 | 3-methyladenine | 3-methyladenine inhibits the reaction [Particulate Matter results in increased expression of MAP1LC3B protein] | 28867211 |
| C025946 | 3-methyladenine | 3-methyladenine inhibits the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form] | 24145604 |
| C025946 | 3-methyladenine | 3-methyladenine inhibits the reaction [vorinostat results in increased expression of MAP1LC3B protein modified form] | 20962572 |
| C025946 | 3-methyladenine | 3-methyladenine inhibits the reaction [Cadmium Chloride results in increased expression of MAP1LC3B protein alternative form] | 21325019 |
| C025946 | 3-methyladenine | 3-methyladenine inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] | 26804720 |
| C025946 | 3-methyladenine | 3-methyladenine results in decreased cleavage of MAP1LC3B protein | 26804720 |
| C025946 | 3-methyladenine | 3-methyladenine results in decreased expression of MAP1LC3B mRNA | 21681844 |
| C025946 | 3-methyladenine | 3-methyladenine inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] | 26804720 |
| C025946 | 3-methyladenine | "3-methyladenine inhibits the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]" | 29128638 |
| C025946 | 3-methyladenine | 3-methyladenine inhibits the reaction [Sirolimus results in increased expression of MAP1LC3B protein modified form] | 18640276 |
| C033643 | 3-nitrofluoranthene | 3-nitrofluoranthene results in increased expression of MAP1LC3B protein | 19041363 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in decreased expression of MAP1LC3B mRNA" | 18648102 |
| C568862 | 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline | "4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline affects the localization of MAP1LC3B protein" | 24161432 |
| C568862 | 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline | "Chloroquine promotes the reaction [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline affects the localization of MAP1LC3B protein]" | 24161432 |
| C517041 | (4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) | "(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) results in increased expression of MAP1LC3B mRNA" | 19561079 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in increased expression of MAP1LC3B mRNA | 19191707 |
| C075773 | 4-phenylbutyric acid | 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] | 26804720 |
| C075773 | 4-phenylbutyric acid | 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] | 26804720 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol affects the metabolism of MAP1LC3B protein]" | 23680031 |
| C550547 | 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide | "6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form]" | 24145604 |
| C003001 | 7-ketocholesterol | 7-ketocholesterol results in increased expression of MAP1LC3B protein | 24445604 |
| C003001 | 7-ketocholesterol | CD38 gene mutant form promotes the reaction [7-ketocholesterol results in increased expression of MAP1LC3B protein] | 24445604 |
| C501332 | ABT-737 | MAP1LC3B mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP3 protein] | 20104024 |
| C501332 | ABT-737 | MAP1LC3B mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP8 protein] | 20104024 |
| C501332 | ABT-737 | MAP1LC3B mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP9 protein] | 20104024 |
| D000079 | Acetaldehyde | Acetaldehyde results in increased lipidation of MAP1LC3B protein | 24492484 |
| D000079 | Acetaldehyde | Cyanamide promotes the reaction [Acetaldehyde results in increased lipidation of MAP1LC3B protein] | 24492484 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of MAP1LC3B mRNA | 21420995|2906747 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of MAP1LC3B protein | 28682524 |
| D000082 | Acetaminophen | chrysin inhibits the reaction [Acetaminophen results in increased expression of MAP1LC3B protein] | 28682524 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Apigenin results in increased expression of MAP1LC3B protein modified form] | 29247770 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [cryptotanshinone results in increased expression of MAP1LC3B protein] | 28600121 |
| D000111 | Acetylcysteine | "Acetylcysteine inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone promotes the reaction [bafilomycin A1 results in increased expression of MAP1LC3B protein]]" | 25301941 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [vorinostat results in increased cleavage of MAP1LC3B protein] | 20543569 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [cadmium acetate affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein]] | 28347754 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [cadmium acetate affects the localization of [RAB7A protein co-treated with MAP1LC3B protein]] | 28347754 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [nonylphenol results in increased expression of MAP1LC3B protein] | 27832966 |
| D020106 | Acrylamide | Acrylamide results in decreased expression of MAP1LC3B mRNA | 28959563 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of MAP1LC3B mRNA | 27153756 |
| D000452 | Aldrin | Aldrin results in decreased expression of MAP1LC3B mRNA | 18579281 |
| C514919 | alpha-solanine | alpha-solanine results in increased expression of MAP1LC3B mRNA | 29247839 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of MAP1LC3B mRNA | 16483693 |
| D000666 | Amphotericin B | Amphotericin B results in increased expression of MAP1LC3B protein | 23988732 |
| D000924 | Anticholesteremic Agents | Anticholesteremic Agents inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of MAP1LC3B mRNA] | 28275691 |
| D000924 | Anticholesteremic Agents | Anticholesteremic Agents inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of MAP1LC3B protein modified form] | 28275691 |
| D000924 | Anticholesteremic Agents | Anticholesteremic Agents results in increased expression of MAP1LC3B protein modified form | 28275691 |
| D047310 | Apigenin | Acetylcysteine inhibits the reaction [Apigenin results in increased expression of MAP1LC3B protein modified form] | 29247770 |
| D047310 | Apigenin | Apigenin results in increased expression of MAP1LC3B protein modified form | 29247770 |
| D047310 | Apigenin | Glutathione inhibits the reaction [Apigenin results in increased expression of MAP1LC3B protein modified form] | 29247770 |
| D001151 | Arsenic | Arsenic results in increased expression of MAP1LC3B protein | 27413109 |
| D001151 | Arsenic | Arsenic results in increased expression of MAP1LC3B protein | 27413109 |
| C019264 | avermectin | avermectin results in increased expression of MAP1LC3B mRNA | 26541719 |
| C019264 | avermectin | avermectin results in increased expression of MAP1LC3B protein | 26541719 |
| C057620 | bafilomycin A | bafilomycin A results in increased cleavage of MAP1LC3B protein | 26378792 |
| C057620 | bafilomycin A | bafilomycin A promotes the reaction [Paraquat results in increased expression of MAP1LC3B protein] | 27246695 |
| C057620 | bafilomycin A | TLR4 protein affects the reaction [bafilomycin A promotes the reaction [Paraquat results in increased expression of MAP1LC3B protein]] | 27246695 |
| C040929 | bafilomycin A1 | "Acetylcysteine inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone promotes the reaction [bafilomycin A1 results in increased expression of MAP1LC3B protein]]" | 25301941 |
| C040929 | bafilomycin A1 | bafilomycin A1 promotes the reaction [resveratrol results in increased expression of MAP1LC3B protein alternative form] | 24145604 |
| C040929 | bafilomycin A1 | bafilomycin A1 results in increased expression of MAP1LC3B protein | 25301941 |
| C040929 | bafilomycin A1 | bafilomycin A1 results in increased expression of MAP1LC3B protein alternative form | 24145604 |
| C040929 | bafilomycin A1 | "[di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone co-treated with bafilomycin A1] results in increased expression of MAP1LC3B mRNA" | 25301941 |
| C040929 | bafilomycin A1 | "di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone promotes the reaction [bafilomycin A1 results in increased expression of MAP1LC3B protein]" | 25301941 |
| C040929 | bafilomycin A1 | resveratrol promotes the reaction [[TNF protein co-treated with bafilomycin A1] results in increased expression of MAP1LC3B protein alternative form] | 24145604 |
| C040929 | bafilomycin A1 | [TNF protein co-treated with bafilomycin A1] results in increased expression of MAP1LC3B protein alternative form | 24145604 |
| C040929 | bafilomycin A1 | bafilomycin A1 results in decreased degradation of MAP1LC3B protein modified form | 26459185 |
| C487081 | belinostat | belinostat results in increased expression of MAP1LC3B mRNA | 19606018 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of MAP1LC3B mRNA | 22316170 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of MAP1LC3B mRNA | 22228805 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MAP1LC3B mRNA" | 19150397|2038263 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of MAP1LC3B protein modified form | 26409479 |
| C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog promotes the reaction [cryptotanshinone results in increased expression of MAP1LC3B protein] | 28600121 |
| C014638 | beta-lapachone | beta-lapachone affects the localization of and results in increased metabolism of MAP1LC3B protein | 21035436 |
| C006780 | bisphenol A | bisphenol A affects the expression of MAP1LC3B mRNA | 21786754 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of MAP1LC3B mRNA | 29027980 |
| C006780 | bisphenol A | bisphenol A results in increased expression of MAP1LC3B protein | 29275510 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of MAP1LC3B promoter | 27312807 |
| C006780 | bisphenol A | bisphenol A affects the expression of MAP1LC3B mRNA | 21786754 |
| C006780 | bisphenol A | bisphenol A affects the expression of MAP1LC3B mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased expression of MAP1LC3B protein modified form | 27539358 |
| C557045 | BO-1051 | BO-1051 results in increased expression of MAP1LC3B protein modified form | 21184746 |
| C557045 | BO-1051 | pepstatin promotes the reaction [BO-1051 results in increased expression of MAP1LC3B protein modified form] | 21184746 |
| D002065 | Buspirone | Buspirone results in increased expression of MAP1LC3B mRNA | 24136188 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of MAP1LC3B mRNA | 15336504 |
| C018475 | butyraldehyde | butyraldehyde results in increased expression of MAP1LC3B mRNA | 26079696 |
| D002104 | Cadmium | Cadmium affects the localization of MAP1LC3B protein | 29111403 |
| D002104 | Cadmium | Cadmium results in increased expression of MAP1LC3B mRNA | 27492225 |
| D002104 | Cadmium | Cadmium results in increased expression of MAP1LC3B protein modified form | 19126599 |
| D002104 | Cadmium | FOXO3 affects the reaction [Cadmium results in increased expression of MAP1LC3B mRNA] | 27492225 |
| C028031 | cadmium acetate | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cadmium acetate affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein]]" | 28347754 |
| C028031 | cadmium acetate | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cadmium acetate affects the localization of [RAB7A protein co-treated with MAP1LC3B protein]]" | 28347754 |
| C028031 | cadmium acetate | 2-aminoethoxydiphenyl borate inhibits the reaction [cadmium acetate affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein]] | 28347754 |
| C028031 | cadmium acetate | 2-aminoethoxydiphenyl borate inhibits the reaction [cadmium acetate affects the localization of [RAB7A protein co-treated with MAP1LC3B protein]] | 28347754 |
| C028031 | cadmium acetate | Acetylcysteine inhibits the reaction [cadmium acetate affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein]] | 28347754 |
| C028031 | cadmium acetate | Acetylcysteine inhibits the reaction [cadmium acetate affects the localization of [RAB7A protein co-treated with MAP1LC3B protein]] | 28347754 |
| C028031 | cadmium acetate | cadmium acetate affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein] | 28347754 |
| C028031 | cadmium acetate | cadmium acetate affects the localization of [RAB7A protein co-treated with MAP1LC3B protein] | 28347754 |
| C028031 | cadmium acetate | Thapsigargin promotes the reaction [cadmium acetate affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein]] | 28347754 |
| C028031 | cadmium acetate | Thapsigargin promotes the reaction [cadmium acetate affects the localization of [RAB7A protein co-treated with MAP1LC3B protein]] | 28347754 |
| D019256 | Cadmium Chloride | 3-methyladenine inhibits the reaction [Cadmium Chloride results in increased expression of MAP1LC3B protein alternative form] | 21325019 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of MAP1LC3B protein alternative form | 21325019 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of MAP1LC3B protein alternative form | 21325019 |
| C071482 | calpeptin | calpeptin inhibits the reaction [dehydroeburicoic acid affects the localization of MAP1LC3B protein] | 19848398 |
| C071482 | calpeptin | calpeptin inhibits the reaction [dehydroeburicoic acid promotes the reaction [MAP1LC3B protein binds to phosphatidylethanolamine]] | 19848398 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of MAP1LC3B mRNA | 17484886 |
| D000068579 | Celecoxib | MAP1LC3B mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP3 protein] | 20104024 |
| D000068579 | Celecoxib | MAP1LC3B mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP8 protein] | 20104024 |
| D000068579 | Celecoxib | MAP1LC3B mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP9 protein] | 20104024 |
| D002635 | Chenodeoxycholic Acid | Chenodeoxycholic Acid results in increased expression of MAP1LC3B protein | 24189133 |
| C100187 | chloropicrin | chloropicrin results in increased expression of MAP1LC3B mRNA | 26352163 |
| D002738 | Chloroquine | [Chloroquine co-treated with TNF protein] results in increased expression of MAP1LC3B protein alternative form | 24145604 |
| D002738 | Chloroquine | "Chloroquine promotes the reaction [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline affects the localization of MAP1LC3B protein]" | 24161432 |
| D002738 | Chloroquine | Chloroquine promotes the reaction [CYP7A1 protein results in increased expression of MAP1LC3B protein modified form] | 28275691 |
| D002738 | Chloroquine | Chloroquine promotes the reaction [Ethanol results in increased expression of MAP1LC3B protein] | 24095927 |
| D002738 | Chloroquine | Chloroquine promotes the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form] | 24145604 |
| D002738 | Chloroquine | Chloroquine results in increased expression of MAP1LC3B mRNA | 24095927 |
| D002738 | Chloroquine | Chloroquine results in increased expression of MAP1LC3B protein | 28600121 |
| D002738 | Chloroquine | Chloroquine results in increased expression of MAP1LC3B protein modified form | 26409479|2827569 |
| D002738 | Chloroquine | cryptotanshinone promotes the reaction [Chloroquine results in increased expression of MAP1LC3B protein] | 28600121 |
| D002738 | Chloroquine | CYP7A1 mRNA promotes the reaction [Chloroquine results in increased expression of MAP1LC3B protein modified form] | 28275691 |
| D002738 | Chloroquine | Paraquat inhibits the reaction [Chloroquine results in increased expression of MAP1LC3B protein modified form] | 26409479 |
| D002738 | Chloroquine | Chloroquine results in increased lipidation of MAP1LC3B protein | 24492484 |
| D002738 | Chloroquine | [Ethanol co-treated with Chloroquine] results in increased lipidation of MAP1LC3B protein | 24492484 |
| D002738 | Chloroquine | Chloroquine results in increased expression of MAP1LC3B mRNA | 17643062 |
| C023676 | chloroquine diphosphate | [chloroquine diphosphate co-treated with Tobacco Smoke Pollution] results in decreased expression of MAP1LC3B mRNA | 27037187 |
| C023676 | chloroquine diphosphate | [chloroquine diphosphate co-treated with Tobacco Smoke Pollution] results in decreased expression of MAP1LC3B protein | 27037187 |
| D002784 | Cholesterol | Cholesterol results in increased expression of MAP1LC3B protein modified form | 28275691 |
| D002788 | Cholesterol Esters | SAN 58035 promotes the reaction [Cholesterol Esters results in increased expression of MAP1LC3B protein modified form] | 28275691 |
| D019826 | Cholic Acid | Cholic Acid results in increased expression of MAP1LC3B protein | 24189133 |
| C043561 | chrysin | chrysin inhibits the reaction [Acetaminophen results in increased expression of MAP1LC3B protein] | 28682524 |
| D002922 | Ciguatoxins | Ciguatoxins affects the expression of MAP1LC3B mRNA | 18353800 |
| D002994 | Clofibrate | Clofibrate results in decreased expression of MAP1LC3B mRNA | 17585979 |
| D002994 | Clofibrate | Clofibrate results in increased expression of MAP1LC3B mRNA | 21318169 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of MAP1LC3B mRNA | 19320972|1937684 |
| D003300 | Copper | "Copper promotes the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone results in increased expression of MAP1LC3B protein]" | 25301941 |
| D003300 | Copper | [Disulfiram binds to Copper] which results in decreased expression of MAP1LC3B mRNA | 24690739 |
| D003300 | Copper | [NSC 689534 binds to Copper] which results in increased expression of MAP1LC3B mRNA | 20971185 |
| D003300 | Copper | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MAP1LC3B mRNA | 15467011 |
| D019327 | Copper Sulfate | Copper Sulfate results in increased expression of MAP1LC3B mRNA | 19549813 |
| D003375 | Coumestrol | Coumestrol results in decreased expression of MAP1LC3B mRNA | 19167446 |
| C037886 | cryptotanshinone | Acetylcysteine inhibits the reaction [cryptotanshinone results in increased expression of MAP1LC3B protein] | 28600121 |
| C037886 | cryptotanshinone | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog promotes the reaction [cryptotanshinone results in increased expression of MAP1LC3B protein] | 28600121 |
| C037886 | cryptotanshinone | cryptotanshinone promotes the reaction [Chloroquine results in increased expression of MAP1LC3B protein] | 28600121 |
| C037886 | cryptotanshinone | cryptotanshinone results in increased expression of MAP1LC3B protein | 28600121 |
| C029892 | cupric chloride | cupric chloride results in increased expression of MAP1LC3B mRNA | 17211630 |
| D003484 | Cyanamide | Cyanamide promotes the reaction [Acetaldehyde results in increased lipidation of MAP1LC3B protein] | 24492484 |
| D003484 | Cyanamide | Cyanamide results in increased lipidation of MAP1LC3B protein | 24492484 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of MAP1LC3B mRNA | 20106945|2163298 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [Ethanol results in increased expression of MAP1LC3B protein] | 24095927 |
| C014347 | decitabine | decitabine inhibits the reaction [sodium arsenite results in increased expression of MAP1LC3B protein] | 19577553 |
| D003676 | Deferoxamine | Deferoxamine results in increased expression of MAP1LC3B protein | 25301941 |
| D003676 | Deferoxamine | Iron affects the reaction [Deferoxamine results in increased expression of MAP1LC3B protein] | 25301941 |
| C547186 | dehydroeburicoic acid | calpeptin inhibits the reaction [dehydroeburicoic acid affects the localization of MAP1LC3B protein] | 19848398 |
| C547186 | dehydroeburicoic acid | calpeptin inhibits the reaction [dehydroeburicoic acid promotes the reaction [MAP1LC3B protein binds to phosphatidylethanolamine]] | 19848398 |
| C547186 | dehydroeburicoic acid | dehydroeburicoic acid affects the localization of MAP1LC3B protein | 19848398 |
| C547186 | dehydroeburicoic acid | dehydroeburicoic acid promotes the reaction [MAP1LC3B protein binds to phosphatidylethanolamine] | 19848398 |
| D003703 | Demecolcine | Demecolcine results in increased expression of MAP1LC3B mRNA | 23649840 |
| D003847 | Deoxyglucose | ATG7 protein promotes the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein] | 20593179 |
| D003847 | Deoxyglucose | Deoxyglucose results in increased prenylation of MAP1LC3B protein | 20593179 |
| D003847 | Deoxyglucose | Mannose inhibits the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein] | 20593179 |
| D003847 | Deoxyglucose | Oxygen deficiency inhibits the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein] | 20593179 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased expression of MAP1LC3B mRNA | 26988607 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of MAP1LC3B mRNA | 20032058 |
| D003907 | Dexamethasone | Testosterone inhibits the reaction [Dexamethasone results in increased expression of MAP1LC3B mRNA] | 20032058 |
| C539263 | di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone | "Acetylcysteine inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone promotes the reaction [bafilomycin A1 results in increased expression of MAP1LC3B protein]]" | 25301941 |
| C539263 | di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone | "ATG5 mutant form inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone results in increased expression of MAP1LC3B protein]" | 25301941 |
| C539263 | di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone | "BECN1 mutant form inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone results in increased expression of MAP1LC3B protein]" | 25301941 |
| C539263 | di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone | "Copper promotes the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone results in increased expression of MAP1LC3B protein]" | 25301941 |
| C539263 | di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone | "[di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone co-treated with bafilomycin A1] results in increased expression of MAP1LC3B mRNA" | 25301941 |
| C539263 | di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone | "di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone promotes the reaction [bafilomycin A1 results in increased expression of MAP1LC3B protein]" | 25301941 |
| C539263 | di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone | "di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone results in increased expression of MAP1LC3B protein" | 25301941 |
| C539263 | di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone | "Iron affects the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone results in increased expression of MAP1LC3B protein]" | 25301941 |
| C023614 | dibenzofuran | dibenzofuran affects the localization of MAP1LC3B protein | 22173198 |
| C023614 | dibenzofuran | dibenzofuran results in increased expression of MAP1LC3B protein modified form | 22173198 |
| D003993 | Dibutyl Phthalate | 3-methyladenine inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] | 26804720 |
| D003993 | Dibutyl Phthalate | 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] | 26804720 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein | 26804720 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of MAP1LC3B mRNA | 21266533 |
| D003993 | Dibutyl Phthalate | 3-methyladenine inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] | 26804720 |
| D003993 | Dibutyl Phthalate | 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] | 26804720 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein | 26804720 |
| D002945 | Cisplatin | Cisplatin results in increased expression of MAP1LC3B mRNA | 19561079|2759478 |
| D002945 | Cisplatin | [Cisplatin results in increased phosphorylation of TP63 protein alternative form] which results in increased expression of MAP1LC3B protein | 21191146 |
| D002945 | Cisplatin | STK11 protein promotes the reaction [[Cisplatin results in increased phosphorylation of TP63 protein alternative form] which results in increased expression of MAP1LC3B protein] | 21191146 |
| D004041 | Dietary Fats | Anticholesteremic Agents inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of MAP1LC3B mRNA] | 28275691 |
| D004041 | Dietary Fats | Anticholesteremic Agents inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of MAP1LC3B protein modified form] | 28275691 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of MAP1LC3B mRNA | 28275691 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of MAP1LC3B protein modified form | 28275691 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of MAP1LC3B protein | 26655953 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of MAP1LC3B mRNA | 19030233 |
| D004041 | Dietary Fats | obeticholic acid inhibits the reaction [Dietary Fats results in decreased expression of MAP1LC3B protein] | 26655953 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of MAP1LC3B mRNA | 27171397 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of MAP1LC3B protein | 27171397 |
| D019422 | Dietary Sucrose | Anticholesteremic Agents inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of MAP1LC3B mRNA] | 28275691 |
| D019422 | Dietary Sucrose | Anticholesteremic Agents inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of MAP1LC3B protein modified form] | 28275691 |
| D019422 | Dietary Sucrose | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of MAP1LC3B mRNA | 28275691 |
| D019422 | Dietary Sucrose | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of MAP1LC3B protein modified form | 28275691 |
| D004178 | Diquat | [Diquat co-treated with procyanidin B2] results in increased expression of MAP1LC3B mRNA | 27057282 |
| D004221 | Disulfiram | [Disulfiram binds to Copper] which results in decreased expression of MAP1LC3B mRNA | 24690739 |
| D004317 | Doxorubicin | [Doxorubicin co-treated with resveratrol] results in increased lipidation of MAP1LC3B protein | 26969377 |
| D004317 | Doxorubicin | Doxorubicin results in increased lipidation of MAP1LC3B protein | 26969377 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased expression of MAP1LC3B mRNA" | 23811387 |
| C118739 | entinostat | entinostat results in increased expression of MAP1LC3B protein modified form | 20962572 |
| C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MAP1LC3B mRNA | 22079256 |
| C572014 | E platinum | 3-methyladenine inhibits the reaction [E platinum results in increased expression of MAP1LC3B protein] | 22322152 |
| C572014 | E platinum | 3-methyladenine inhibits the reaction [E platinum results in increased metabolism of MAP1LC3B protein] | 22322152 |
| C572014 | E platinum | E platinum results in increased expression of MAP1LC3B protein | 22322152 |
| C572014 | E platinum | E platinum results in increased metabolism of MAP1LC3B protein | 22322152 |
| D000431 | Ethanol | Chloroquine promotes the reaction [Ethanol results in increased expression of MAP1LC3B protein] | 24095927 |
| D000431 | Ethanol | Ethanol results in increased expression of MAP1LC3B mRNA | 24095927 |
| D000431 | Ethanol | Ethanol results in increased expression of MAP1LC3B protein | 24095927 |
| D000431 | Ethanol | ATG7 mutant form inhibits the reaction [Ethanol results in increased lipidation of MAP1LC3B protein] | 24492484 |
| D000431 | Ethanol | Dactinomycin inhibits the reaction [Ethanol results in increased expression of MAP1LC3B protein] | 24095927 |
| D000431 | Ethanol | [Ethanol co-treated with Chloroquine] results in increased lipidation of MAP1LC3B protein | 24492484 |
| D000431 | Ethanol | Ethanol promotes the reaction [FOXO3 protein binds to MAP1LC3B promoter] | 25460735 |
| D000431 | Ethanol | Ethanol results in increased expression of MAP1LC3B mRNA | 24095927|2449248 |
| D000431 | Ethanol | Ethanol results in increased expression of MAP1LC3B protein | 24095927 |
| D000431 | Ethanol | Ethanol results in increased lipidation of MAP1LC3B protein | 24492484 |
| D000431 | Ethanol | fomepizole inhibits the reaction [Ethanol results in increased lipidation of MAP1LC3B protein] | 24492484 |
| D000431 | Ethanol | FOXO3 gene mutant form inhibits the reaction [Ethanol results in increased expression of MAP1LC3B mRNA] | 24095927 |
| D000431 | Ethanol | FOXO3 protein affects the reaction [Ethanol results in increased expression of MAP1LC3B mRNA] | 24095927 |
| D000431 | Ethanol | NR1H4 gene mutant form inhibits the reaction [Ethanol promotes the reaction [FOXO3 protein binds to MAP1LC3B promoter]] | 25460735 |
| D000431 | Ethanol | NR1H4 gene mutant form inhibits the reaction [Ethanol results in increased expression of MAP1LC3B mRNA] | 25460735 |
| D000431 | Ethanol | resveratrol promotes the reaction [Ethanol results in increased expression of MAP1LC3B mRNA] | 24095927 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of MAP1LC3B mRNA | 17555576 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of MAP1LC3B mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MAP1LC3B mRNA | 17942748 |
| D005020 | Ethyl Methanesulfonate | Ethyl Methanesulfonate results in increased expression of MAP1LC3B mRNA | 23649840 |
| C000499 | ferric oxide | ferric oxide analog results in increased expression of MAP1LC3B protein | 24068039 |
| D018120 | Finasteride | Finasteride results in increased expression of MAP1LC3B mRNA | 24136188 |
| D005419 | Flavonoids | Flavonoids results in decreased expression of MAP1LC3B mRNA | 18035473 |
| D005472 | Fluorouracil | MAP1LC3B protein affects the susceptibility to Fluorouracil | 15548681 |
| D005485 | Flutamide | Flutamide results in increased expression of MAP1LC3B mRNA | 24136188 |
| C010238 | fomepizole | fomepizole inhibits the reaction [Ethanol results in increased lipidation of MAP1LC3B protein] | 24492484 |
| D005557 | Formaldehyde | Formaldehyde results in increased expression of MAP1LC3B mRNA | 23649840 |
| D005557 | Formaldehyde | Formaldehyde results in increased expression of MAP1LC3B mRNA | 24142868 |
| C069837 | fullerene C60 | fullerene C60 results in increased expression of MAP1LC3B mRNA | 19167457 |
| C007845 | gingerol | [gingerol co-treated with Hydrogen Peroxide] results in increased expression of MAP1LC3B protein modified form | 27451028 |
| D005897 | Glafenine | Glafenine results in increased expression of MAP1LC3B mRNA | 24136188 |
| D005947 | Glucose | "3-methyladenine inhibits the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]" | 29128638 |
| D005947 | Glucose | Glucose results in decreased expression of MAP1LC3B protein | 29128638 |
| D005947 | Glucose | "N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]" | 29128638 |
| D005947 | Glucose | "Sirolimus promotes the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]" | 29128638 |
| D005947 | Glucose | ULK1 protein affects the reaction [Glucose results in decreased expression of MAP1LC3B protein] | 29128638 |
| D005947 | Glucose | "ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]" | 29128638 |
| D005947 | Glucose | [INS protein co-treated with Glucose] results in decreased expression of MAP1LC3B mRNA | 22634610 |
| D005978 | Glutathione | Glutathione inhibits the reaction [Apigenin results in increased expression of MAP1LC3B protein modified form] | 29247770 |
| D005978 | Glutathione | Glutathione deficiency results in increased expression of MAP1LC3B mRNA | 15345336 |
| D017313 | Fenretinide | Fenretinide results in increased expression of MAP1LC3B mRNA | 16671099 |
| D017313 | Fenretinide | Fenretinide results in increased expression of MAP1LC3B mRNA | 28973697 |
| D006861 | Hydrogen Peroxide | [gingerol co-treated with Hydrogen Peroxide] results in increased expression of MAP1LC3B protein modified form | 27451028 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of MAP1LC3B mRNA | 20044591 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of MAP1LC3B protein alternative form | 23726866 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of MAP1LC3B protein alternative form | 23726866 |
| D006861 | Hydrogen Peroxide | [Hydrogen Peroxide co-treated with procyanidin B2] results in increased expression of MAP1LC3B mRNA | 27057282 |
| C005044 | hydroxyethyl methacrylate | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased expression of MAP1LC3B mRNA] | 28184909 |
| C005044 | hydroxyethyl methacrylate | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased expression of MAP1LC3B protein] | 28184909 |
| C005044 | hydroxyethyl methacrylate | hydroxyethyl methacrylate results in increased expression of MAP1LC3B mRNA | 28184909 |
| C005044 | hydroxyethyl methacrylate | hydroxyethyl methacrylate results in increased expression of MAP1LC3B protein | 28184909 |
| C492448 | ICG 001 | ICG 001 results in increased expression of MAP1LC3B mRNA | 26191083 |
| D007501 | Iron | Iron affects the reaction [Deferoxamine results in increased expression of MAP1LC3B protein] | 25301941 |
| D007501 | Iron | "Iron affects the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone results in increased expression of MAP1LC3B protein]" | 25301941 |
| C544151 | jinfukang | jinfukang results in decreased expression of MAP1LC3B mRNA | 27392435 |
| C005134 | juglone | juglone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] | 20479004 |
| C410337 | K 7174 | K 7174 results in increased expression of MAP1LC3B mRNA | 24086573 |
| D048628 | Ketolides | Ketolides analog results in decreased expression of MAP1LC3B mRNA | 24967691 |
| D007854 | Lead | Lead affects the expression of MAP1LC3B mRNA | 28903495 |
| C045463 | leflunomide | leflunomide results in increased expression of MAP1LC3B mRNA | 28988120 |
| C045463 | leflunomide | leflunomide results in increased expression of MAP1LC3B mRNA | 24136188 |
| D001556 | Lindane | Lindane results in increased expression of MAP1LC3B mRNA | 17785943 |
| D008298 | Maleates | ATG5 mutant form inhibits the reaction [Maleates results in increased expression of MAP1LC3B protein] | 21976531 |
| D008298 | Maleates | Maleates results in increased expression of MAP1LC3B protein | 21976531 |
| D008358 | Mannose | Mannose inhibits the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein] | 20593179 |
| D008727 | Methotrexate | Methotrexate results in increased expression of MAP1LC3B mRNA | 21678067 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of MAP1LC3B mRNA | 28001369 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of MAP1LC3B protein modified form | 27667695 |
| C004925 | methylmercuric chloride | ATG5 promotes the reaction [methylmercuric chloride results in increased cleavage of MAP1LC3B protein] | 27667695 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased cleavage of MAP1LC3B protein | 27667695 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of MAP1LC3B protein modified form | 27667695 |
| C004925 | methylmercuric chloride | U 0126 inhibits the reaction [methylmercuric chloride results in increased expression of MAP1LC3B protein modified form] | 27667695 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of MAP1LC3B mRNA | 23649840 |
| D008774 | Methylphenidate | Methylphenidate results in decreased expression of MAP1LC3B mRNA | 22470460 |
| D008797 | Metyrapone | [Metyrapone co-treated with Vitamin K 3] results in increased expression of MAP1LC3B protein | 19819344 |
| C531525 | N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide | "3-methyladenine inhibits the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]" | 29128638 |
| C531525 | N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide | "N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]" | 29128638 |
| C531525 | N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide | "Sirolimus promotes the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]" | 29128638 |
| C531525 | N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide | "ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]" | 29128638 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of MAP1LC3B protein" | 24389112 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of MAP1LC3B mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of MAP1LC3B mRNA" | 25620056 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of MAP1LC3B mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of MAP1LC3B mRNA" | 25620056 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of MAP1LC3B protein" | 24929217 |
| D009285 | Naphthoquinones | Naphthoquinones results in increased expression of MAP1LC3B mRNA | 23811387 |
| C051752 | nefazodone | nefazodone results in increased expression of MAP1LC3B mRNA | 24136188 |
| D019888 | Nelfinavir | Nelfinavir results in increased expression of MAP1LC3B protein | 20594311 |
| D019888 | Nelfinavir | Tamoxifen promotes the reaction [Nelfinavir results in increased expression of MAP1LC3B protein] | 20594311 |
| C012655 | nimesulide | nimesulide results in increased expression of MAP1LC3B mRNA | 24136188 |
| C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in increased expression of MAP1LC3B mRNA | 17616710 |
| C025256 | nonylphenol | Acetylcysteine inhibits the reaction [nonylphenol results in increased expression of MAP1LC3B protein] | 27832966 |
| C025256 | nonylphenol | nonylphenol affects the expression of MAP1LC3B protein | 27832966 |
| C025256 | nonylphenol | nonylphenol results in increased cleavage of MAP1LC3B protein | 27832966 |
| C558013 | NSC 689534 | [NSC 689534 binds to Copper] which results in increased expression of MAP1LC3B mRNA | 20971185 |
| C464660 | obeticholic acid | obeticholic acid inhibits the reaction [Dietary Fats results in decreased expression of MAP1LC3B protein] | 26655953 |
| D016627 | Oxidopamine | Oxidopamine results in increased expression of MAP1LC3B protein modified form | 28802652 |
| C529674 | OSU-HDAC42 compound | OSU-HDAC42 compound results in increased expression of MAP1LC3B protein modified form | 20962572 |
| D010100 | Oxygen | Oxygen deficiency inhibits the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein] | 20593179 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of MAP1LC3B mRNA | 23624791 |
| D017239 | Paclitaxel | Paclitaxel results in increased expression of MAP1LC3B mRNA | 19815708 |
| D017239 | Paclitaxel | Paclitaxel results in increased expression of MAP1LC3B protein | 19815708 |
| C016030 | pantogab | pantogab results in increased expression of MAP1LC3B mRNA | 17379144 |
| D010269 | Paraquat | Paraquat inhibits the reaction [Chloroquine results in increased expression of MAP1LC3B protein modified form] | 26409479 |
| D010269 | Paraquat | Paraquat results in increased expression of MAP1LC3B mRNA | 27220436 |
| D010269 | Paraquat | bafilomycin A promotes the reaction [Paraquat results in increased expression of MAP1LC3B protein] | 27246695 |
| D010269 | Paraquat | Paraquat results in increased expression of MAP1LC3B protein | 25092649|2724669 |
| D010269 | Paraquat | TLR4 protein affects the reaction [bafilomycin A promotes the reaction [Paraquat results in increased expression of MAP1LC3B protein]] | 27246695 |
| D010269 | Paraquat | TLR4 protein affects the reaction [Paraquat results in increased expression of MAP1LC3B protein] | 27246695 |
| D052638 | Particulate Matter | 3-methyladenine inhibits the reaction [Particulate Matter results in increased expression of MAP1LC3B protein] | 28867211 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of MAP1LC3B protein | 28867211 |
| D052638 | Particulate Matter | spautin-1 inhibits the reaction [Particulate Matter results in increased expression of MAP1LC3B protein] | 28867211 |
| C568608 | PCI 5002 | [PCI 5002 co-treated with Zinc] results in increased expression of MAP1LC3B mRNA | 18593933 |
| C031375 | pepstatin | pepstatin promotes the reaction [BO-1051 results in increased expression of MAP1LC3B protein modified form] | 21184746 |
| C023036 | perfluorooctanoic acid | ATG5 protein promotes the reaction [perfluorooctanoic acid results in increased expression of MAP1LC3B protein modified form] | 26879310 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of MAP1LC3B protein modified form | 26879310 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of MAP1LC3B mRNA | 26879310 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of MAP1LC3B protein modified form | 26879310 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of MAP1LC3B mRNA | 19159669 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of MAP1LC3B mRNA | 19162173 |
| C483858 | phosphatidylethanolamine | calpeptin inhibits the reaction [dehydroeburicoic acid promotes the reaction [MAP1LC3B protein binds to phosphatidylethanolamine]] | 19848398 |
| C483858 | phosphatidylethanolamine | dehydroeburicoic acid promotes the reaction [MAP1LC3B protein binds to phosphatidylethanolamine] | 19848398 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of MAP1LC3B mRNA | 18301758|1844570 |
| C006253 | pirinixic acid | PPARA protein affects the reaction [pirinixic acid results in increased expression of MAP1LC3B mRNA] | 21318169 |
| D010938 | Plant Oils | Plant Oils results in increased expression of MAP1LC3B mRNA | 23370395 |
| C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MAP1LC3B mRNA | 22079256 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in increased expression of MAP1LC3B mRNA | 22079256|2271453 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in increased expression of MAP1LC3B mRNA | 28903501 |
| C479580 | procyanidin B2 | [Diquat co-treated with procyanidin B2] results in increased expression of MAP1LC3B mRNA | 27057282 |
| C479580 | procyanidin B2 | [Hydrogen Peroxide co-treated with procyanidin B2] results in increased expression of MAP1LC3B mRNA | 27057282 |
| D011374 | Progesterone | Progesterone results in decreased expression of MAP1LC3B mRNA | 23018184 |
| D011374 | Progesterone | Progesterone results in increased expression of MAP1LC3B mRNA | 23018184 |
| D011794 | Quercetin | Quercetin results in increased expression of MAP1LC3B mRNA | 21632981 |
| C059514 | resveratrol | 3-methyladenine inhibits the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form] | 24145604 |
| C059514 | resveratrol | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol affects the metabolism of MAP1LC3B protein]" | 23680031 |
| C059514 | resveratrol | "6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form]" | 24145604 |
| C059514 | resveratrol | ATG5 protein affects the reaction [resveratrol affects the metabolism of MAP1LC3B protein] | 23680031 |
| C059514 | resveratrol | ATG5 protein affects the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form] | 24145604 |
| C059514 | resveratrol | bafilomycin A1 promotes the reaction [resveratrol results in increased expression of MAP1LC3B protein alternative form] | 24145604 |
| C059514 | resveratrol | BECN1 protein affects the reaction [resveratrol affects the metabolism of MAP1LC3B protein] | 23680031 |
| C059514 | resveratrol | BECN1 protein affects the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form] | 24145604 |
| C059514 | resveratrol | Chloroquine promotes the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form] | 24145604 |
| C059514 | resveratrol | [Doxorubicin co-treated with resveratrol] results in increased lipidation of MAP1LC3B protein | 26969377 |
| C059514 | resveratrol | Niacinamide inhibits the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form] | 24145604 |
| C059514 | resveratrol | resveratrol affects the metabolism of MAP1LC3B protein | 23680031 |
| C059514 | resveratrol | resveratrol promotes the reaction [[TNF protein co-treated with bafilomycin A1] results in increased expression of MAP1LC3B protein alternative form] | 24145604 |
| C059514 | resveratrol | resveratrol results in increased expression of MAP1LC3B mRNA | 23750556 |
| C059514 | resveratrol | resveratrol results in increased expression of MAP1LC3B protein alternative form | 24145604 |
| C059514 | resveratrol | resveratrol results in increased lipidation of MAP1LC3B protein | 26969377 |
| C059514 | resveratrol | SIRT1 protein affects the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form] | 24145604 |
| C059514 | resveratrol | [TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form | 24145604 |
| C059514 | resveratrol | resveratrol promotes the reaction [Ethanol results in increased expression of MAP1LC3B mRNA] | 24095927 |
| C059514 | resveratrol | resveratrol results in increased expression of MAP1LC3B mRNA | 24095927 |
| D012402 | Rotenone | Rotenone results in decreased expression of MAP1LC3B mRNA | 23186747 |
| D012402 | Rotenone | Rotenone results in increased expression of MAP1LC3B protein | 26847702 |
| D012402 | Rotenone | wortmannin inhibits the reaction [Rotenone results in increased expression of MAP1LC3B protein] | 26847702 |
| C513635 | S-2-pentyl-4-pentynoic hydroxamic acid | S-2-pentyl-4-pentynoic hydroxamic acid results in increased expression of MAP1LC3B mRNA | 21427059 |
| C113180 | S 3483 | [S 3483 co-treated with Vitamin K 3] results in increased expression of MAP1LC3B protein | 19819344 |
| C040256 | SAN 58035 | SAN 58035 promotes the reaction [Cholesterol Esters results in increased expression of MAP1LC3B protein modified form] | 28275691 |
| D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased expression of MAP1LC3B mRNA" | 24735948 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of MAP1LC3B mRNA | 25895662 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of MAP1LC3B protein | 23806026 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of MAP1LC3B protein alternative form | 28161448 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of MAP1LC3B mRNA | 19073995 |
| D012834 | Silver | Silver results in increased expression of MAP1LC3B mRNA | 26014281 |
| D012834 | Silver | Silver results in increased expression of MAP1LC3B protein modified form | 28987793 |
| D019821 | Simvastatin | Simvastatin results in increased expression of MAP1LC3B protein | 23817226 |
| D019821 | Simvastatin | Simvastatin results in increased expression of MAP1LC3B protein | 23817226 |
| D020123 | Sirolimus | Sirolimus affects the metabolism of MAP1LC3B protein | 23680031 |
| D020123 | Sirolimus | Sirolimus results in increased expression of MAP1LC3B mRNA | 19815708 |
| D020123 | Sirolimus | Sirolimus results in increased expression of MAP1LC3B protein | 19815708|2710778 |
| D020123 | Sirolimus | Sirolimus results in increased expression of MAP1LC3B protein modified form | 21212465 |
| D020123 | Sirolimus | CD38 gene mutant form promotes the reaction [Sirolimus results in increased expression of MAP1LC3B protein] | 24445604 |
| D020123 | Sirolimus | Sirolimus results in increased expression of MAP1LC3B mRNA | 21681844 |
| D020123 | Sirolimus | Sirolimus results in increased expression of MAP1LC3B protein | 24445604 |
| D020123 | Sirolimus | 3-methyladenine inhibits the reaction [Sirolimus results in increased expression of MAP1LC3B protein modified form] | 18640276 |
| D020123 | Sirolimus | Sirolimus affects the localization of MAP1LC3B protein | 18640276 |
| D020123 | Sirolimus | "Sirolimus promotes the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of MAP1LC3B protein]]" | 29128638 |
| D020123 | Sirolimus | Sirolimus results in increased expression of MAP1LC3B protein modified form | 18640276 |
| C009277 | sodium arsenate | sodium arsenate results in increased expression of MAP1LC3B mRNA | 23922661 |
| C017947 | sodium arsenite | decitabine inhibits the reaction [sodium arsenite results in increased expression of MAP1LC3B protein] | 19577553 |
| C017947 | sodium arsenite | MIR21 mRNA affects the reaction [sodium arsenite results in increased expression of MAP1LC3B protein] | 27107786 |
| C017947 | sodium arsenite | PTEN protein affects the reaction [MIR21 mRNA affects the reaction [sodium arsenite results in increased expression of MAP1LC3B protein]] | 27107786 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of MAP1LC3B mRNA | 28595984 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of MAP1LC3B protein | 19577553|2643215 |
| C017947 | sodium arsenite | U 0126 inhibits the reaction [sodium arsenite results in increased expression of MAP1LC3B protein] | 19577553|2710778 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of MAP1LC3B protein | 27413109 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of MAP1LC3B mRNA | 19072884 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of MAP1LC3B protein | 26432159 |
| D018038 | Sodium Selenite | "[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in increased expression of MAP1LC3B protein modified form" | 28757135 |
| D012999 | Soman | Soman results in increased expression of MAP1LC3B mRNA | 19281266 |
| C000591235 | spautin-1 | spautin-1 inhibits the reaction [Particulate Matter results in increased expression of MAP1LC3B protein] | 28867211 |
| D013629 | Tamoxifen | MAP1LC3B protein results in decreased susceptibility to Tamoxifen | 20479004 |
| D013629 | Tamoxifen | Tamoxifen promotes the reaction [Nelfinavir results in increased expression of MAP1LC3B protein] | 20594311 |
| D013629 | Tamoxifen | Tamoxifen results in increased expression of MAP1LC3B protein | 25301941 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of MAP1LC3B mRNA | 17555576 |
| D013656 | Taurocholic Acid | Taurocholic Acid results in increased expression of MAP1LC3B protein | 24189133 |
| C047246 | temozolomide | temozolomide results in increased expression of MAP1LC3B protein | 19567134 |
| C047246 | temozolomide | Thalidomide promotes the reaction [temozolomide results in increased expression of MAP1LC3B protein] | 19567134 |
| D013739 | Testosterone | Testosterone inhibits the reaction [Dexamethasone results in increased expression of MAP1LC3B mRNA] | 20032058 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of MAP1LC3B mRNA | 21570461 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MAP1LC3B mRNA | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of MAP1LC3B mRNA | 19770486 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of MAP1LC3B mRNA | 22298810 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of MAP1LC3B mRNA | 16054898|1846511 |
| D013755 | Tetradecanoylphorbol Acetate | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] | 20479004 |
| D013755 | Tetradecanoylphorbol Acetate | E2F4 protein promotes the reaction [PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein]] | 20479004 |
| D013755 | Tetradecanoylphorbol Acetate | E2F4 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] | 20479004 |
| D013755 | Tetradecanoylphorbol Acetate | EGR1 protein promotes the reaction [PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein]] | 20479004 |
| D013755 | Tetradecanoylphorbol Acetate | EGR1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] | 20479004 |
| D013755 | Tetradecanoylphorbol Acetate | juglone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] | 20479004 |
| D013755 | Tetradecanoylphorbol Acetate | PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] | 20479004 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein | 20479004 |
| C009438 | tetrandrine | tetrandrine results in increased expression of MAP1LC3B | 26822499 |
| D013792 | Thalidomide | Thalidomide promotes the reaction [temozolomide results in increased expression of MAP1LC3B protein] | 19567134 |
| D019284 | Thapsigargin | Thapsigargin affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein] | 28347754 |
| D019284 | Thapsigargin | Thapsigargin affects the localization of [RAB7A protein co-treated with MAP1LC3B protein] | 28347754 |
| D019284 | Thapsigargin | Thapsigargin promotes the reaction [cadmium acetate affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein]] | 28347754 |
| D019284 | Thapsigargin | Thapsigargin promotes the reaction [cadmium acetate affects the localization of [RAB7A protein co-treated with MAP1LC3B protein]] | 28347754 |
| C009495 | titanium dioxide | titanium dioxide analog results in increased expression of MAP1LC3B protein | 25111187 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of MAP1LC3B mRNA | 28065790 |
| D014028 | Tobacco Smoke Pollution | [chloroquine diphosphate co-treated with Tobacco Smoke Pollution] results in decreased expression of MAP1LC3B mRNA | 27037187 |
| D014028 | Tobacco Smoke Pollution | [chloroquine diphosphate co-treated with Tobacco Smoke Pollution] results in decreased expression of MAP1LC3B protein | 27037187 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of MAP1LC3B mRNA | 22003194 |
| C012589 | trichostatin A | trichostatin A affects the expression of MAP1LC3B mRNA | 28542535 |
| C012589 | trichostatin A | trichostatin A affects the localization of MAP1LC3B protein modified form | 20543569 |
| C012589 | trichostatin A | trichostatin A results in increased cleavage of MAP1LC3B protein | 20543569 |
| C012589 | trichostatin A | trichostatin A results in increased expression of MAP1LC3B mRNA | 19606018 |
| C012589 | trichostatin A | trichostatin A results in increased expression of MAP1LC3B protein modified form | 20962572 |
| C467051 | trifloxystrobin | trifloxystrobin results in increased expression of MAP1LC3B protein alternative form | 27853101 |
| C046488 | trimethyltin | trimethyltin results in decreased degradation of MAP1LC3B protein modified form | 26459185 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in increased expression of MAP1LC3B mRNA" | 26179874 |
| D017973 | Tungsten Compounds | Tungsten Compounds results in increased expression of MAP1LC3B mRNA | 28666766 |
| D014415 | Tunicamycin | Tunicamycin results in increased expression of MAP1LC3B protein modified form | 20962572 |
| D014415 | Tunicamycin | Tunicamycin results in increased prenylation of MAP1LC3B protein | 20593179 |
| C113580 | U 0126 | U 0126 inhibits the reaction [sodium arsenite results in increased expression of MAP1LC3B protein] | 19577553|2710778 |
| C113580 | U 0126 | U 0126 inhibits the reaction [methylmercuric chloride results in increased expression of MAP1LC3B protein modified form] | 27667695 |
| D014520 | Urethane | Urethane results in increased expression of MAP1LC3B mRNA | 28818685 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of MAP1LC3B mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of MAP1LC3B mRNA | 22083351|2317975 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of MAP1LC3B mRNA | 17292431|1796380 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of MAP1LC3B mRNA | 20546886|2142705 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of MAP1LC3B mRNA | 21318169 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of MAP1LC3B gene | 25560391 |
| D014750 | Vincristine | Vincristine results in increased expression of MAP1LC3B mRNA | 23649840 |
| D009536 | Niacinamide | Niacinamide inhibits the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form] | 24145604 |
| D024483 | Vitamin K 3 | [Metyrapone co-treated with Vitamin K 3] results in increased expression of MAP1LC3B protein | 19819344 |
| D024483 | Vitamin K 3 | [S 3483 co-treated with Vitamin K 3] results in increased expression of MAP1LC3B protein | 19819344 |
| C111237 | vorinostat | 3-methyladenine inhibits the reaction [vorinostat results in increased expression of MAP1LC3B protein modified form] | 20962572 |
| C111237 | vorinostat | Acetylcysteine inhibits the reaction [vorinostat results in increased cleavage of MAP1LC3B protein] | 20543569 |
| C111237 | vorinostat | ATG7 protein promotes the reaction [vorinostat results in increased cleavage of MAP1LC3B protein] | 17881280 |
| C111237 | vorinostat | BECN1 protein promotes the reaction [vorinostat results in increased cleavage of MAP1LC3B protein] | 17881280 |
| C111237 | vorinostat | TSC2 protein promotes the reaction [vorinostat results in increased cleavage of MAP1LC3B protein] | 17881280 |
| C111237 | vorinostat | vorinostat affects the localization of MAP1LC3B protein modified form | 20543569 |
| C111237 | vorinostat | vorinostat results in increased cleavage of MAP1LC3B protein | 17881280|2054356 |
| C111237 | vorinostat | vorinostat results in increased expression of MAP1LC3B mRNA | 22083351 |
| C111237 | vorinostat | vorinostat results in increased expression of MAP1LC3B protein modified form | 20962572 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Rotenone results in increased expression of MAP1LC3B protein] | 26847702 |
| C009687 | wortmannin | wortmannin results in decreased expression of MAP1LC3B protein | 26847702 |
| D015032 | Zinc | [PCI 5002 co-treated with Zinc] results in increased expression of MAP1LC3B mRNA | 18593933 |
| D015034 | Zinc Oxide | Zinc Oxide results in increased expression of MAP1LC3B protein | 29289694 |
| D015034 | Zinc Oxide | MAP1LC3B mutant form inhibits the reaction [Zinc Oxide analog results in increased cleavage of CASP3 protein] | 24614525 |